On March 5, 2025, The Hospital for Sick Children (SickKids) received a significant breakthrough in pediatric research with an $11.7 million award from Genome Canada. As part of the Canadian Precision Health Initiative, a total of $81 million in...

Mar 17, 2025
On March 5, 2025, The Hospital for Sick Children (SickKids) received a significant breakthrough in pediatric research with an $11.7 million award from Genome Canada. As part of the Canadian Precision Health Initiative, a total of $81 million in...
Feb 20, 2025
After eight transformative years at the Ted Rogers Centre for Heart Research (TRCHR), Dr. Soror Sharifpoor is embarking on an exciting new chapter in her career. As the Director of Strategy & Translation at the Translational Biology and Engineering Program (TBEP)...
Dec 2, 2024
With a mission to support novel approaches to managing and preventing heart failure, the Ted Rogers Centre for Heart Research uses its Innovation Fund to propel emerging research with great potential. The 2024-25 Innovation Fund Seed Grants are currently open and you...
Nov 21, 2024
The Ted Rogers Centre for Heart Research is delighted to welcome Iris Cohn as the new Innovator in Genomic Translation - also recently promoted to Director of the Pharmacogenetics (PGx) Program at The Hospital for Sick Children. A trained pharmacist, Iris established...
Oct 30, 2024
NorthMiRs Inc., an innovative cardiovascular biotech start-up, has won $250,000 in funding from the Ted Rogers Centre for Heart Research’s Entrepreneurship for Cardiovascular Health Opportunities (ECHO) PITCH 2024 competition. Since its launch in 2018, the ECHO...
Oct 15, 2024
Congenital heart disease (CHD) is the most commonly occurring birth anomaly. Despite a strong genetic basis, almost 90% of cases remain genetically undiagnosed. However, the surge of new technology is enabling a search for hidden gene defects not detectable on...
Echocardiography is a non-invasive clinical tool for clinicians to obtain critical information about cardiac structure and function.
New imaging techniques, such as strain echocardiography, enable detailed evaluation that provides highly comprehensive information on left ventricular myocardial function. In cancer patients, peak systolic global longitudinal strain (GLS) measurements help clinicians understand what changes are happening to a patient’s heart muscle (myocardium) before a significant decline in left ventricular function or heart failure during and after cancer therapy.
On this site, we provide educational materials to help those who wish to start performing GLS measurements during routine echocardiography. We include a protocol that outlines techniques for image acquisition, optimization and post-processing analysis of the data.
After reviewing the supporting material, if you are comfortable with the concepts of strain imaging and post processing, 10 case studies are available for download or online analysis depending on your chosen vendor. These are real-life cases from patients in our cardio-oncology program, followed with echocardiography and cardiac MRI. All have had long term follow-up.
The 10 cases include patients who did and did not develop a significant change in GLS (also confirmed by cardiac MRI) during their cancer therapy. The cases also include images obtained both at baseline and at the time of a significant change in GLS. Therefore, analyzing these cases provides the user the ability to measure strain on real life cases where the outcomes are verified using an external reference standard and clinical follow-up.
Uniquely and most importantly, users have the ability to send their analysis (both actual images and the GLS values) back to us for comparison with our measurements. Our expert team will let you know whether, based on your measurements, the determination of cardiotoxicity status (i.e. present or absence) would be consistent with our findings. Furthermore, we will provide targeted feedback if you send us your images. This provides an opportunity to not only compare your measurement values to that of ours, but also to identify ways to enhance your measurement process.
Once the first set of images are returned to us we will provide you comprehensive feedback. This will be followed by 20 additional cases (again verified by cardiac MRI) which would be available to you for re-analyses. Once this data is provided back to us, we will again provide you back personalized feedback and also illustrate whether there has been an improvement in the agreement of your measurements with that of ours. This sequence is meant to build confidence in performing strain measurements in your laboratories.
Please note that this is a learning opportunity and performing these analyses does not “certify” you to perform strain imaging. Finally, we also ask for your permission to use the results of the first and second measurements anonymously to determine whether this learning process is effective. Our findings may also potentially be used for academic publications or to inform other educational endeavours using only aggregate data.